Literature DB >> 24833148

Mortality indicators and risk factors for intra-abdominal hypertension in severe acute pancreatitis.

J G Zhao1, Q Liao, Y P Zhao, Y Hu.   

Abstract

This study assessed the risk factors associated with mortality and the development of intra-abdominal hypertension (IAH) in patients with severe acute pancreatitis (SAP). To identify significant risk factors, we assessed the following variables in 102 patients with SAP: age, gender, etiology, serum amylase level, white blood cell (WBC) count, serum calcium level, Acute Physiology and Chronic Health Evaluation II (APACHE-II) score, computed tomography severity index (CTSI) score, pancreatic necrosis, surgical interventions, and multiple organ dysfunction syndrome (MODS). Statistically significant differences were identified using the Student t test and the χ (2) test. Independent risk factors for survival were analyzed by Cox proportional hazards regression. The following variables were significantly related to both mortality and IAH: WBC count, serum calcium level, serum amylase level, APACHE-II score, CTSI score, pancreatic necrosis, pancreatic necrosis >50%, and MODS. However, it was found that surgical intervention had no significant association with mortality. MODS and pancreatic necrosis >50% were found to be independent risk factors for survival in patients with SAP. Mortality and IAH from SAP were significantly related to WBC count, serum calcium level, serum amylase level, APACHE-II score, CTSI score, pancreatic necrosis, and MODS. However, Surgical intervention did not result in higher mortality. Moreover, MODS and pancreatic necrosis >50% predicted a worse prognosis in SAP patients.

Entities:  

Keywords:  Intra-abdominal hypertension; Mortality; Risk factors; Severe acute pancreatitis

Mesh:

Year:  2014        PMID: 24833148      PMCID: PMC4027909          DOI: 10.9738/INTSURG-D-13-00182.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  23 in total

1.  A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis.

Authors:  Vikesh K Singh; Bechien U Wu; Thomas L Bollen; Kathryn Repas; Rie Maurer; Richard S Johannes; Koenraad J Mortele; Darwin L Conwell; Peter A Banks
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

Review 2.  Risk assessment in acute pancreatitis.

Authors:  R Mofidi; P V Patil; S A Suttie; R W Parks
Journal:  Br J Surg       Date:  2009-02       Impact factor: 6.939

3.  The impact of hospital volume on outcomes in acute pancreatitis: a case for centers of excellence?

Authors:  Bechien U Wu
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

Review 4.  From acute pancreatitis to end-organ injury: mechanisms of acute lung injury.

Authors:  Tercio De Campos; Jessica Deree; Raul Coimbra
Journal:  Surg Infect (Larchmt)       Date:  2007-02       Impact factor: 2.150

5.  Intra-abdominal pressure as a marker of severity in acute pancreatitis.

Authors:  Jose Manuel Hidalgo Rosas; Salvador Navarro Soto; Javier Serra Aracil; Pere Rebasa Cladera; Raquel Hernandez Borlan; Antonia Vazquez Sanchez; Felip Bory Ros; Luis Grande Posa
Journal:  Surgery       Date:  2006-09-18       Impact factor: 3.982

6.  Abdominal compartment syndrome in patients with severe acute pancreatitis in early stage.

Authors:  Hong Chen; Fei Li; Jia-Bang Sun; Jian-Guo Jia
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

7.  Morbimortality indicators in severe acute pancreatitis.

Authors:  Tercio De Campos; Cinara Cerqueira; Laíse Kuryura; José Gustavo Parreira; Silvia Soldá; Jacqueline A G Perlingeiro; José Cesar Assef; Samir Rasslan
Journal:  JOP       Date:  2008-11-03

Review 8.  Acute pancreatitis: diagnosis, prognosis, and treatment.

Authors:  Jennifer K Carroll; Brian Herrick; Teresa Gipson; Suzanne P Lee
Journal:  Am Fam Physician       Date:  2007-05-15       Impact factor: 3.292

9.  Recommendations for research from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome.

Authors:  J J De Waele; M L Cheatham; M L N G Malbrain; A W Kirkpatrick; M Sugrue; Z Balogh; R Ivatury; B De Keulenaer; E J Kimball
Journal:  Acta Clin Belg       Date:  2009 May-Jun       Impact factor: 1.264

10.  Clinical relevance of intra-abdominal hypertension in patients with severe acute pancreatitis.

Authors:  Ahmed Z Al-Bahrani; Ghalib H Abid; Adrian Holt; Rory F McCloy; Jonathan Benson; Jane Eddleston; Basil J Ammori
Journal:  Pancreas       Date:  2008-01       Impact factor: 3.327

View more
  5 in total

1.  Integrated traditional Chinese medicine improves acute pancreatitis via the downregulation of PRSS1 and SPINK1.

Authors:  Qiang Gao; Nusheng Liang
Journal:  Exp Ther Med       Date:  2015-01-20       Impact factor: 2.447

2.  Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome.

Authors:  Michał Lipiński; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2017-06-13

3.  Leukocyte cell population data from the blood cell analyzer as a predictive marker for severity of acute pancreatitis.

Authors:  Yihui Wang; Zhihong Xu; Yuhua Zhou; Mengqi Xie; Xing Qi; Zhiwei Xu; Qi Cai; Huiqiu Sheng; Erzhen Chen; Bing Zhao; Enqiang Mao
Journal:  J Clin Lab Anal       Date:  2021-06-01       Impact factor: 2.352

4.  Angiopoietin-2 Is an Early Indicator of Acute Pancreatic-Renal Syndrome in Patients with Acute Pancreatitis.

Authors:  Mateusz Sporek; Paulina Dumnicka; Agnieszka Gala-Bladzinska; Piotr Ceranowicz; Zygmunt Warzecha; Artur Dembinski; Ewa Stepien; Jerzy Walocha; Ryszard Drozdz; Marek Kuzniewski; Beata Kusnierz-Cabala
Journal:  Mediators Inflamm       Date:  2016-02-28       Impact factor: 4.711

5.  Open necrosectomy in acute pancreatitis-obsolete or still useful?

Authors:  Henrik Leonard Husu; Jouni Antero Kuronen; Ari Kalevi Leppäniemi; Panu Juhani Mentula
Journal:  World J Emerg Surg       Date:  2020-03-17       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.